ADVERTISEMENT
RSV vaccine design concept art
RSV Vaccines That Work?
Multiple candidates are in Phase 3 clinical trials for older adults and pregnant women, with some getting close to approval in the United States.
RSV Vaccines That Work?
RSV Vaccines That Work?

Multiple candidates are in Phase 3 clinical trials for older adults and pregnant women, with some getting close to approval in the United States.

Multiple candidates are in Phase 3 clinical trials for older adults and pregnant women, with some getting close to approval in the United States.

RSV

Illustration of viruses represented with different colors overlapping each other.
What Happens When You Catch More than One Virus?
Alejandra Manjarrez, PhD | Dec 7, 2022 | 8 min read
The “tripledemic” shines a spotlight on viral interference, in which one infection can block another.
A vial labeled “RSV vaccine” on a reflective surface next to a syringe.
After Decades of Delays, RSV Vaccines Show Promise in Early Data 
Dan Robitzski | Nov 1, 2022 | 3 min read
Both Pfizer and GSK have shared preliminary data suggesting that their experimental vaccines can protect older adults and newborn infants from the virus.
Micrograph of influenza A virus and RSV
Flu/RSV Coinfection Produces Hybrid Virus that Evades Immune Defenses
Catherine Offord | Oct 25, 2022 | 2 min read
When fused to RSV, influenza A virus is better able to escape antibodies that usually neutralize it, an in vitro study finds.
three children outside with winter gear wearing surgical masks
The Pandemic Crushed the Flu—What Happens When It Returns?
Diana Kwon | Jul 7, 2021 | 8 min read
Cases of influenza and other respiratory viruses sank dramatically during the pandemic, with potential implications for both people and pathogens.  
b cell crispr immunity rsv respiratory syncitial virus
CRISPRed B Cells Produce Antibodies Against Hard-to-Treat Viruses
Katarina Zimmer | May 17, 2019 | 5 min read
In line with previous research, a new study in mice demonstrates that B cells can be engineered to ward off infections, this time against respiratory syncytial virus (RSV).
ADVERTISEMENT